Newest studies
Every summary in our library, newest first, as a dated timeline.
Showing 5,326–5,350 of 27,380 studies, newest first · page 214 of 1096.
February 2025 25
-
2025-02-03
Home as mind: AI extenders and affective ecologies in dementia care
37/100 ✓ Peer-reviewed Caregiving Synthese
Key finding: I consider applications of “AI extenders” to dementia care.
Full summary, score breakdown and related studies → Original source
-
2025-02-03
Extreme Heat and Hospitalization Among Older Persons With Alzheimer Disease and Related Dementias
63/100 ✓ Peer-reviewed Risk factors JAMA Internal Medicine
Key finding: The sample included 3 329 977 beneficiaries (2 126 290 [63.9%] female, 33 887 [1.0%] Asian, 354 771 [10.7%] Black, 61 515 [1.8%] Hispanic, 2 831 391 [85.0%] White, and 891 815 [26.8%] dual eligible for Medicaid). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-03
Bioaccumulation of microplastics in decedent human brains
64/100 ✓ Peer-reviewed Getting a diagnosis Nature medicine
Key finding: MNPs in these organs primarily consist of polyethylene, with lesser but significant concentrations of other polymers. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-03
Ultrasound Neuromodulation With Transcranial Pulse Stimulation in Alzheimer Disease: A Randomized Clinical Trial
66/100 ✓ Peer-reviewed Treatments JAMA network open
Key finding: For the intention-to-treat analysis, 60 patients between ages 51 and 82 years (mean [SD], 70.65 [8.16] years; 30 females; 30 males) were included. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-03
Alzheimer Disease Blood Biomarkers and Cognition Among Individuals With Diabetes and Overweight or Obesity
73/100 ✓ Peer-reviewed Biomarkers JAMA network open
Key finding: The mean (SD) baseline age of 758 participants was 61.5 (6.1) years, and 424 participants [55.9%] were female. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-03
A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests
79/100 ✓ Peer-reviewed Biomarkers Brain
Key finding: Plasma %p-tau217WashU had the highest performance, with significantly higher AUCs than all the immunoassays (Pdiff < 0.007). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-02
Network models of late life depression symptoms and cognitive impairments across time
64/100 ✓ Peer-reviewed Risk factors Aging & mental health
Key finding: Across 3544 participants, ≥65 years of age, with no diagnosed dementia-related disorders, the depression symptom everything was an effort showed high expected influence across all time points. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02 month only
Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PET
55/100 ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association
Key finding: Interquartile range differences in amyloid beta 42/40, percent phosphorylated tau 217 (%p-tau217), and Amyloid Probability Score 2 were associated with 1.29 (P = 0.09), 1.38 (P < 0.001), and 1.20 (P = 0.05) increases, respectively, in the hazard of progression from A- to A+ and 0.27 (P = 0.16), 0.50 (P = 0.007), and 0.28 (P = 0.15) Centiloid/year increases, respectively, in annual rate of amyloid PET change. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02 month only
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data
46/100 ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association
Key finding: Models including plasma biomarkers yielded the most accurate predictions of tau-PET burden (best model: R-squared = 0.66-0.69), with especially high contribution from plasma phosphorylated tau-217 (p-tau217). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02 month only
Novel plasma biomarkers of amyloid plaque pathology and cortical thickness: Evaluation of the NULISA targeted proteomic platform in an ethnically diverse cohort
50/100 ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association
Key finding: On NULISA, phosphorylated tau (p-tau217, p-tau231, and p-tau181), glial fibrillary acidic protein (GFAP), and microtubule-associated protein tau (MAPT-tau) showed the top significant association with amyloid beta (Aβ) positron emission tomography (PET) status, followed by the neuroinflammation markers C-C motif ligand 2 (CCL2), chitotriosidase 1 (CHIT1) and interleukin-8 (CXCL8), and the synaptic marker neurogranin (NRGN). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02 month only
A head-to-head comparison of plasma biomarkers to detect Alzheimer's disease in a memory clinic
66/100 ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association
Key finding: Plasma p-tau biomarkers had a greater diagnostic performance and larger effect sizes compared to t-tau and Aβ42/40 assays in detecting Aβ pathology. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-01
Examining multimorbidity contributors to dementia over time
52/100 ✓ Peer-reviewed Vascular contributions Alzheimer s & Dementia
Key finding: Hypertension, acute myocardial infarction, atrial fibrillation, diabetes, heart failure, ischemic heart disease, stroke, and arthritis additively accounted for 71.8% (95% confidence interval [CI]: 62.9%-79.1%) of ADRD incident cases based on LE-AAF. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-01
Lower Retinal Arteriolar Density Is Associated With Higher Cerebral Small Vessel Disease Burden: An Optical Coherence Tomography Angiography Study
40/100 ✓ Peer-reviewed Vascular contributions Brain and Behavior
Key finding: 246 older adults (mean age = 58.84 ± 7.00 years; 38.21 % males) were included in our data analysis. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-01
Protocol for a meta-review of interventions to prevent and manage ICU delirium
54/100 ✓ Peer-reviewed Clinical safety BMJ Open
Key finding: ICU delirium is also associated with increased mortality and dementia in the longer term. +2 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-01
Impact of frailty status on the effect of a multidomain lifestyle intervention on cognition
52/100 ✓ Peer-reviewed Prevention trials Age and Ageing
Key finding: Frailty status (prefrail/frail n = 520, robust n = 625) at baseline did not modify the effect of intervention on global cognition during the 2-year follow-up (P-value for frailty × intervention × time interaction > .05). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-01
Relationship between Alzheimer's Disease and Type 2 Diabetes: Critical Review On Cellular and Molecular Common Pathogenic Mechanisms
31/100 ✓ Peer-reviewed Disease mechanisms Current Alzheimer Research
Key finding: Both diseases exhibit common genetic, epigenetic, biochemical and physiological characteristics. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-01
The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias
38/100 ✓ Peer-reviewed Disease mechanisms Alzheimer s & Dementia
Key finding: Our findings indicate that the prevention and treatment of vascular health may be a potential target for ADRD combination therapy. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2025-02-01
Effect of Steroids on the Progression of Alzheimer's Dementia: A Retrospective Chart Review
37/100 ✓ Peer-reviewed Inflammation and the immune system Aging Medicine
Key finding: In our study, steroid use delayed the progression of dementia. +2 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-01
Bidirectional relationship between epigenetic age and stroke, dementia, and late-life depression
55/100 ✓ Peer-reviewed Brain tissue and pathology Nature Communications
Key finding: Participants with a prior brain health event are 4% epigenetically older (β = 0.04, SE = 0.01), indicating these conditions are associated with accelerated aging beyond that captured by chronological age. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-01
Dissociable spatial topography of cortical atrophy in early‐onset and late‐onset Alzheimer's disease: A head‐to‐head comparison of the LEADS and ADNI cohorts
46/100 ✓ Peer-reviewed Long-term cohort studies Alzheimer s & Dementia
Key finding: After controlling for the level of cognitive impairment, we found a double dissociation between AD clinical phenotype and localization/magnitude of atrophy, characterized by predominant neocortical involvement in EOAD and more focal anterior medial temporal involvement in LOAD. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-01
Perspective: Emerging challenges for a future ADNI
44/100 ✓ Peer-reviewed Long-term cohort studies Alzheimer s & Dementia
Key finding: In the last two decades, the Alzheimer's Disease Neuroimaging Initiative (ADNI) has significantly advanced our understanding, technologies, and methods for detecting and diagnosing Alzheimer's disease and related dementias.
Full summary, score breakdown and related studies → Original source
-
2025-02-01
Associations of Frailty Status and Sleep Quality With Incident Delirium: A Prospective Study in the UK Biobank
46/100 ✓ Peer-reviewed Long-term cohort studies CNS Neuroscience & Therapeutics
Key finding: During a median follow-up of 13.8 years, 6554 (1.9%) cases of incident delirium were documented. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-01
Associations of Mid‐ and Late‐Life Fasting Blood Glucose Levels With Dementia Risk Among Patients With Diabetes: Framingham Heart Study
44/100 ✓ Peer-reviewed Long-term cohort studies European Journal of Neurology
Key finding: Higher FBG level at midlife was not associated with an increased risk of dementia. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-02-01
Etomidate ameliorates Alzheimer-like neuropathology and cognitive impairment in APP/PS1 mice
26/100 ✓ Peer-reviewed Risk genes beyond APOE Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
Key finding: In conclusion, etomidate ameliorates Alzheimer-like neuropathology and cognitive impairment in APP/PS1 mice, indicating that etomidate may be a potentially useful drug for the treatment of AD.
Full summary, score breakdown and related studies → Original source
-
2025-02-01
Sex-specific effects of apolipoprotein E ε4 genotype on longitudinal hippocampal atrophy in amnestic mild cognitive impairment over a 2-year evaluation period
44/100 ✓ Peer-reviewed Mild cognitive impairment Journal of Alzheimer s Disease
Key finding: We identified that the APOE4 genotype affected ΔHV in females. +4 more findings
Full summary, score breakdown and related studies → Original source
Browse the library by subject, with the full score breakdown →